— Know what they know.
Not Investment Advice

NAUT NASDAQ

Nautilus Biotechnolgy, Inc.
1W: +103.6% 1M: +103.8% 3M: +13.9% YTD: +2.6% 1Y: +134.7% 3Y: -38.9% 5Y: -70.4%
$1.96
+0.39 (+24.84%)
 
Weekly Expected Move ±23.0%
$1 $2 $2 $2 $3
NASDAQ · Healthcare · Biotechnology · Tech Score Buy · Power 63 · $249.4M mcap · 56M float · 2.46% daily turnover · Short 50% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
+0.0% YoY
$-57M
Net Income
+14.0% YoY
$-52M
Free Cash Flow
+7.9% YoY
693.2%
Gross Margin
-8296.3%
Op. Margin
-7615.3%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-36.2%
ROA-30.0%
ROIC-66.2%

Valuation

P/E-4.4
P/B1.9
EV/EBITDA-3.4

Leverage

Debt/Equity0.21
Current Ratio10.14
Interest Cov.0.0x

Quality Scores

Piotroski F3/9
Altman Z0.71
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms